Latest Headlines

  1. Protective Equipment Is Critically Important For Ebola Responders

    The rare Ebola virus has set out on another deadly rampage. This latest outbreak in the Democratic Republic of Congo is the worst in the country’s history—more than 400 people have died from the epidemic since August. Obviously tragic for its victims, the virus threatens the healthcare providers who care for these victims as well.

  2. Pharmaceutical Hot Melt Extrusion Training Courses Available

    This course teaches the process principles of the functional operation of the ZSK twin screw compounder in pharmaceutical hot melt extrusion. We deal with the special fields of application in detail and present the latest Coperion developments. You also receive information about the scale-up process, troubleshooting and interlocks.

  3. Single-Use Technology For Biologics Manufacturing In St. Louis, Missouri

    Watch this video and learn about Thermo Fisher Scientific’s expansion of its biologics site in St. Louis, Missouri. The facility will be the single largest single-use technology CDMO in the United States.

  4. Thermo Fisher Continues To Expand Its Outsourcing Capacity To Meet The Continued Strong Demand For Commercialization Services

    In 2018, the Pharma Services biologics business within Thermo Fisher Scientific, supported the commercialization of two new therapeutics for its clients. The St. Louis, Missouri and the Groningen, Netherlands sites both completed FDA Pre-Approval Inspections (PAIs) and received Establishment Inspection Reports (EIRs) for the commercial manufacture of biologic therapies.

  5. Tablet Development And Scale-Up Training Course Announced For Feb 25-27 In Telford PA

    This three-day course provides comprehensive insight into the tablet development process and scale-up challenges with the same unique classroom and hands-on training you have come to expect from Natoli.

  6. Continuous Pharmaceutical Manufacturing: Insights From Regulators

    In the highly regulated pharmaceutical industry, manufacturers can’t help but wonder what regulatory authorities like the FDA think of emerging technologies. So what do the global authorities have to say about continuous manufacturing?

  7. Collaboration Of Waters And Pfizer Improves mAb And ADC Separations; Leads To New Column Chemistry

    Monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) are the fastest-growing class of therapeutic agents. Close to 50 mAb-related products have been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of diseases as diverse as cancer, cardiovascular, neurological, autoimmune, and inflammatory diseases.

  8. How To Avoid Residual Solvent When Drying HPLC Fractions

    Driven by the requirement for completely dry samples, pharmaceutical compound handling groups are increasingly using SP Scientific’s Genevac LyoSpeed, a hybrid process combining conventional centrifugal evaporation and lyophilization, as their preferred method for drying HPLC reverse-phase solvent fractions.

  9. Beacon Pharmaceuticals To Invest In New Life Sciences Facility In Jupiter FL

    Beacon Pharmaceutical, a focused early-stage life sciences firm, will build a state-of-the-art life sciences accelerator and biologics synthesis facility at a relocated facility in Jupiter, Florida.

  10. Meissner Announces New Manufacturing Facility In Castlebar, Ireland

    At a press conference in Ireland on 01 FEB 2019, Meissner Filtration Products announced that it will expand manufacturing operations by establishing a facility in County Mayo, Ireland, creating upwards of 150 jobs over the next 5 years.